Category: Philips Healthcare
A jury delivers a $467 million verdict for Masimo in a patent infringement spat with Royal Philips over pulse oximetry technology.
Here's a look at some of the top Wall Street stories for medical device companies this week: TriVascular Tech's stent graft recall could hurt the bottom line; Alere unveils $3.82B privatization plan; Medtronic, Covidien slide on new U.S. inversion rules; Baxano puts itself on the auction block; Philips to carve out lighting biz, merger healthcare & consumer units
The U.S. Defense Dept. awards rivals Philips Healthcare and Zoll Medical separate contracts to supply airworthy defibrillators.
Royal Philips reveals plans to spin out its legacy lighting business and merge Philips Healthcare and its consumer business into a new 'HealthTech' unit.
Bluegrass Vascular Technologies taps former ArthroCare R&D chief Gabriele Niederauer to be its new president & CEO.
Bluegrass Vascular Technologies said it named Gabriele Niederauer its new president & CEO, hard on the heels of a Series A funding round that brought in $4.5 million for its Surfacer central venous catheter.
, Biolase Technology Inc.
, Bluegrass Vascular Technologies
, Bovie Medical Corp.
, Copan Group
, European Society of Cardiology
, Evaluate Ltd.
, LED Medical Diagnostics Inc.
, Medina Medical
, Philips Healthcare
, Smith & Nephew
, TYRX Inc.
A federal appeals court upholds the U.S. Patent & Trademark Office's decision not to review 8 defibrillator patents owned by Philips Healthcare and dismisses the case.
Here's a look at some of the top regulatory stories for medical device companies this week: Philips wins FDA nod for 3D TAVI planning software; Direct Flow wins CE Marks for TAVI device; FDA OKs return of Covidien's Pipeline embolism device; FDA delays UDI rule for contacts, intraocular lenses; Cardiovascular Systems recalls some Diamondback devices on embolism risk